微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.4% | 38.61% | 22.81% | 71/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.14% | 10.68% | 115.09% | 67/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 0.53% | -93.21% | -74.15% | 88/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.05% | -74.28% | 102.97% | 85/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.01% | -81.23% | -1.94% | 85/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.03% | -64.11% | -86.81% | 69/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 7.81% | 4.27% | -2.01% | 44/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 7.97% | -9.23% | 48.14% | 34/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 5.38% | 2.48% | 87.46% | 32/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.87% | 2.14% | -61.68% | 31/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.49% | 6.54% | -14.69% | 55/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.78% | 5.4% | 67.24% | 36/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.25% | 1.55% | 86.83% | 43/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.81% | -3.77% | -60.03% | 46/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 7.03% | -9.99% | -15.61% | 82/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.33% | 1.59% | 61.12% | 66/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 5.17% | -21.31% | 77.05% | 68/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.92% | -27.54% | -62.61% | 57/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 7.81% | -5.45% | -4.76% | 94/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 8.2% | -59.53% | 24.81% | 71/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.57% | 45.35% | 63.03% | 61/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 4.03% | -65.5% | -51.21% | 41/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 8.26% | 122.69% | -59.23% | 97/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 20.26% | 94.81% | 348.23% | 27/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.52% | -25.41% | -61.3% | 75/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 11.68% | 210.64% | 132.09% | 3/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -36.4% | -409.26% | -450% | 118/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 10.4% | 9.13% | 71.62% | 28/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 6.06% | 2.19% | 61.17% | 34/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 3.76% | 2.73% | -68.05% | 14/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 11.77% | -6.14% | 23.5% | 62/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 9.53% | -8.98% | 60.71% | 25/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 5.93% | 5.7% | 62.02% | 23/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 3.66% | 12.96% | -70.81% | 20/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 12.54% | 13.07% | 19.77% | 54/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 10.47% | -3.32% | 86.63% | 21/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 5.61% | 4.66% | 73.15% | 30/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.24% | 12.5% | -70.78% | 16/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 11.09% | -26.26% | 2.4% | 51/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 10.83% | -14.05% | 102.05% | 13/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 5.36% | -43.04% | 86.11% | 25/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 2.88% | -62.35% | -80.85% | 14/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |